The findings suggest that Gypenoside XLIX may promote mitochondrial autophagy in neuronal cells and reduce intracellular ROS accumulation by regulating the PI3K/AKT/FOXO1 signaling pathway, which could potentially alleviate stroke-related damage. The gene discussed is FOXO1; the disease is stroke disorder.